← Back to feed

Venture Life Group

VLG · AIM · Personal Care, Drug and Grocery Stores · mcap £84m today, £74m on 9 Dec

Cash shell · Forming 1/2 Creeping towards 30 % · Early 1/3

Pattern evidence · every line sourced

Disposal completes, 9 Dec: Venture Life (AIM: VLG), a leader in product innovation, development and commercialisation within the global consumer healthcare sector, announces that, further to the disclosure made in the FY24 Final Results announcement, it has completed the sale of its Ultradex and Dentyl brands, including... RNS
Watch: next signal would be “Net cash ≈ market cap” – Net cash (ex leases) in the first results after the sale ≥ 50% of today's market cap, within 400 days.

AI summary with checked claims arrives with the nightly run. These lines are the matched extracts.

All announcements

All RNS · 148 Key events · 25 Pattern signals · 1

06 Oct 26

Transfer of Treasury Shares Voting rights down

Venture Life Group PLC (AIM: VLG), a leader in product innovation, development and commercialisation within the global consumer healthcare sector, announces that today the Company transferred 110,000 ordinary shares of 0.3p each in the Company (“Ordinary...
RNS 9809520 ↗
01 Oct 26

Director/PDMR Shareholding Director buys

Venture Life (AIM: VLG), a leader in product innovation, development and commercialisation within the global consumer healthcare sector, announces that Daniel Wells, Chief Financial Officer, has today purchased 14,760 ordinary shares of 0.3 pence each in...
RNS 9802433 ↗
30 Sep 26

Director/PDMR Shareholding Director buys

Venture Life (AIM: VLG), a leader in product innovation, development and commercialisation within the global consumer healthcare sector, announces that Daniel Wells, Chief Financial Officer, has today purchased 38,717 ordinary shares of 0.3 pence each in...
RNS 9798975 ↗
29 Sep 26

Holding(s) in Company Holder at 25–30 %

TR-1: Standard form for notification of major holdings
RNS 9797038 ↗
29 Sep 26

Final Results and CEO Succession

Final results for the seventeen month period ended 31 May 2026
RNS 9795249 ↗
24 Sep 26

Investor Presentation via Investor Meet Company

Venture Life (AIM: VLG) is pleased to announce that Jerry Randall (CEO), Daniel Wells (CFO) and Kate Bache (Chief Innovation & Marketing Officer) will provide a live presentation relating to the Final Results for the 17-month period ended 31 May 2026 via...
RNS 9789996 ↗
20 Aug 26

Share Buyback Programme BuybackVoting rights down

Venture Life Group plc (AIM: VLG), a recognised leader in proactive healthy longevity, product innovation, development, and commercialisation within the global consumer healthcare sector, is pleased to announce the decision to extend its share buyback...
RNS 9730804 ↗
27 Jul 26

Transfer of Treasury Shares

Venture Life Group PLC (AIM: VLG), a leader in product innovation, development and commercialisation within the global consumer healthcare sector, announces that it has today transferred 70,000 ordinary shares of 0.3p each in the Company ("Ordinary...
RNS 9689233 ↗
22 Jul 26

Transfer of Treasury Shares

Transfer of Treasury Shares & Transaction in Own Shares
RNS 9682694 ↗
14 Jul 26

Transfer of Treasury Shares

Venture Life Group PLC (AIM: VLG), a leader in product innovation, development and commercialisation within the global consumer healthcare sector, announces that on 13th July 2026 the Company transferred 129,000 ordinary shares of 0.3p each in the Company...
RNS 9668794 ↗
13 Jul 26

Transfer of Treasury Shares

Venture Life Group PLC (AIM: VLG), a leader in product innovation, development and commercialisation within the global consumer healthcare sector, announces that on 10th July 2026 the Company transferred 257,500 ordinary shares of 0.3p each in the Company...
RNS 9664214 ↗
30 Jun 26

Director/PDMR Shareholding Director buys

Venture Life (AIM: VLG), a recognised leader in proactive longevity, health innovation and global commercialisation within the global consumer healthcare sector, announces that Paul McGreevy, Non-Executive Chairman, has today purchased 93,887 ordinary...
RNS 9645118 ↗
30 Jun 26

Full Year Trading Update

Revenue and Adjusted EBITDA in line with management expectations
RNS 9642994 ↗
04 Jun 26

Director/PDMR Shareholding Director buys

Venture Life (AIM: VLG), a recognised leader in proactive longevity, health innovation and global commercialisation within the global consumer healthcare sector, announces that Paul McGreevy, Non-Executive Chairman, purchased 88,273 ordinary shares of 0.3...
RNS 9600703 ↗
03 Jun 26

Acquisition of FemiClear and CUROXEN

Venture Life (AIM: VLG), a recognised leader in proactive longevity, health innovation and global commercialisation within the consumer healthcare sector, is pleased to announce the acquisition of FemiClear, and CUROXEN (together with FemiClear, the...
RNS 9598392 ↗
31 Mar 26

Half-year Results Voting rights down

Unaudited Interim Results for the 12-month period ended 31 December 2025
RNS 9499192 ↗
26 Mar 26

Investor Presentation via Investor Meet Company

Venture Life (AIM: VLG) is pleased to announce that Jerry Randall (CEO), Daniel Wells (CFO) and Kate Bache (Chief Innovation & Marketing Officer) will provide a live presentation relating to the Interim Results for the 12 month period ended 31 December...
RNS 9493676 ↗
13 Feb 26

Holding(s) in Company Holder at 25–30 %

TR-1: Standard form for notification of major holdings
RNS 9430920 ↗
12 Feb 26

PCA Dealing Director buys

Venture Life Group PLC (AIM: VLG), a recognised leader in proactive healthy, product innovation, development, and commercialisation within the global consumer healthcare sector, announces that it was notified on 11 February 2026 that Lewis Arthur, a PCA of...
RNS 9428905 ↗
30 Jan 26

Exercise of Share Options & Total Voting Rights

Exercise of Share Options & Total Voting Rights
RNS 9396991 ↗
26 Jan 26

Trading Update

Venture Life (AIM: VLG), a leader in product innovation, development and commercialisation within the global consumer healthcare sector, announces a trading update for the twelve-month period ended 31 December 2025 (the "Period").
RNS 9385628 ↗
20 Jan 26

Exercise of Share Options & Total Voting Rights

Exercise of Share Options & Total Voting Rights
RNS 9367648 ↗
18 Dec 25

Exercise of Share Options & Total Voting Rights

Exercise of Share Options & Total Voting Rights
RNS 9307223 ↗
17 Dec 25

Holding(s) in Company Activist stake

TR-1: Standard form for notification of major holdings
RNS 9304068 ↗
09 Dec 25

SIGNAL 1 Disposal completes

Venture Life (AIM: VLG), a leader in product innovation, development and commercialisation within the global consumer healthcare sector, announces that, further to the disclosure made in the FY24 Final Results announcement, it has completed the sale of its...
Sale of Non-Core Products · RNS 9283745 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.